<DOC>
	<DOCNO>NCT01601314</DOCNO>
	<brief_summary>The purpose study determine relationship magnesium sulphate administration level S100B protein serum patient undergoing supratentorial brain parenchymal resection .</brief_summary>
	<brief_title>Perioperative Magnesium Sulphate Cerebral Protector Neurosurgical Patients</brief_title>
	<detailed_description />
	<mesh_term>Seizures</mesh_term>
	<mesh_term>Magnesium Sulfate</mesh_term>
	<criteria>Male female older 18 year . Undergoing supratentorial parenchyma resection surgery . Capable collaborate probe exploration include study . Signature write informed consent form . Life expectancy le 12 month due suspect histological type tumour . Hypothalamicpituitary axis illness . Presence Melanoma previously . Glomerular filtration rate le 60 mL/min . Thyroid parathyroid gland pathology . Myasthenia gravis . Respiratory depression . Pregnancy breastfeeding .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>May 2016</verification_date>
</DOC>